Helping new therapies developed in the lab today reach patients in the clinic tomorrow
At Stanford, we are positioned to deliver the best possible care to children and adults using minimally invasive image-guided approaches to enable both Precision Sampling as well as Precision Delivery.
The interventional radiology team at LPCH has a progressive and pioneering culture where advanced technologies are combined with innovative approaches, for both routine patient care as well as new interventional clinical trials.
Specifically, at LPCH we have state-of-the-art interventional facilities unlike any other place in the world which helps us to bring innovation directly to children so they can receive the best possible treatment.
Research-driven Pioneering Care
Clinical Trials We are leading multiple efforts to bring the latest technologies and innovative approaches to the patient’s bedside. Dr Thakor is actively involved in multiple clinical trials as a PI as well as a Co-PI or collaborator; some of these efforts include patients being treated with new technologies like high intensity focused ultrasound (HIFU), innovative procedures like autologous and allogenic islet transplantation, and pushing the boundaries for local delivery of therapies into the arterial supply of organs, like the bowel for children with IBD (i.e. Cronh’s disease and ulcerative colitis) or GvHD. Our vision is to allow IRIS to innovate in the laboratory and then seamlessly facilitate the translation of precision therapies (i.e. MSCs and MSC-EVs) into validated and optimized precision delivery pathways thereby enabling the treatment of diseases like kidney injury, liver injury, bowel injury, diabetes and organ rejection.
Minimally Invasive Approaches for 21st Century Care Interventional Radiologists are at the cutting-edge interface of medical innovation and can integrate multiple imaging modalities with advanced technologies to deliver minimally invasive care for patients. These technologies include imaging equipment (i.e. fluoroscopic machines which use low dose x-rays, ultrasound machines that use soundwaves and MRI machines that use magnetic fields and radiowaves), machines that can cause focal tissue destruction (i.e. radiofrequency ablation, cryoablation, microwave ablation, soundwave/HIFU ablation), equipment that can be deployed in blood vessels and luminal structures (i.e. particles, coils, filters, stents) and software programs that help guide interventions (i.e. fusion software for target localization or vessel mapping software for target vessel selection).